Consensus EPS · Q3 2026
$1.98
Consensus revenue · Q3 2026
$6.6B
Analysts
15
Last reported
Jul 21, 2026
Analyst consensus
Based on estimates from 15 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $6.6B | $6.6B | $6.7B |
| EPS | $1.91 | $1.98 | $2.02 |
| EBITDA | $2B | $2B | $2B |
| EBIT | $1.7B | $1.7B | $1.8B |
| Net income | $1.4B | $1.4B | $1.4B |
- Revenue$6.6B
- EPS$1.98
- EBITDA$2B
- EBIT$1.7B
- Net income$1.4B
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q3 2026 | $7.4B | $7.3B | +1.7% | $2.96 | $2.90 | +2.2% |
| Q1 2026 | $7.3B | $7.4B | -1.4% | $3.29 | $3.22 | +2.1% |
- Q3 2026+1.7%+2.2%
- Q1 2026-1.4%+2.1%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
No community consensus
No TickerLeague members predicted Marsh & McLennan Companies (MRSH) Q3 2026 before it reported.
Analyst price target
Based on price targets from 7 analysts.
- Low
- $180.00
- Consensus
- $204.25
- Median
- $206.50
- High
- $234.00
- Current
- $175.99
- Upside
- +16.1%
Upside calculated vs most recent trading price of $175.99.
Consensus across all covering analysts. See the ranking ›
Analyst ratings
Consensus: Hold — based on 34 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 22, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Jul 22, 2026 | Mizuho | maintain | Neutral | Neutral |
| Jul 22, 2026 | Citigroup | downgrade | Buy | Neutral |
| Jul 13, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Jul 10, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Jul 9, 2026 | Mizuho | maintain | Neutral | Neutral |
| Jul 9, 2026 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Jul 8, 2026 | UBS | maintain | Buy | Buy |
| Jul 6, 2026 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jun 9, 2026 | UBS | maintain | Buy | Buy |
- Jul 22, 2026Wells FargoEqual Weight
- Jul 22, 2026MizuhoNeutral
- Jul 22, 2026CitigroupNeutral
- Jul 13, 2026JP MorganOverweight
- Jul 10, 2026Evercore ISI GroupOutperform
- Jul 9, 2026MizuhoNeutral
- Jul 9, 2026Cantor FitzgeraldOverweight
- Jul 8, 2026UBSBuy
- Jul 6, 2026Morgan StanleyEqual Weight
- Jun 9, 2026UBSBuy
Frequently asked questions
Marsh & McLennan Companies (MRSH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks3.41% TTM
- Dividend Profile2.61% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.